Published in Women's Health Weekly, October 30th, 2008
"The receptor activator of nuclear factor kappaB ligand (RANKL) is an important regulator of bone metabolism. The aim of this investigation was to evaluate potential age-and gender-related changes in free RANKL and total RANKL (free RANKL+RANKL/osteoprotegerin complexes). Two hundred and forty...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly